Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 4, Issue 1, 2007, Pages 5-13

  Lindberg, Anne ^a,b   Larsson, Lars Gunnar ^a   Rönmark, Eva ^a,c   Jonsson, Ann Christin ^a   Larsson, Kjell ^c   Lundbäck, Bo ^a,c  

^a SUNDERBY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

COPD; Decline in FEV1; Gender; Incidence; Respiratory symptoms; Risk factors

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SPIROMETRY; STRUCTURED INTERVIEW; AGED; ANALYSIS OF VARIANCE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; SOCIAL CLASS; STANDARD; SWEDEN; VITAL CAPACITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; SOCIAL CLASS; SPIROMETRY; SWEDEN; VITAL CAPACITY;

EID: 33847407161     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550601168358     Document Type: Article

References (39)

1. Anto JM, Vermiere P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001 May; 17(5):982-994.
2. Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis 2001; 56(3):261-264.
3. 1. Eur Respir J 1989; 2(9):811-816.
4. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46:863-870.
5. Sobradillo V, Miravitlles M, Jimenez CA, Gabriel R, Viejo JL, Masa JF, Fernandez-Fau L, Villsante C. [Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation]. Arch Bronchoneumol 1999; 35(4):159-166.
6. Mannino DM, Gahnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160:1683-1989.
7. Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A-C, Jönsson E, Larsson L-G, Andersson S, Sandström T, Lundbäck B. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97(2):115-122.
8. Huhti E, Ikkala J. A follow-up study on respiratory symptoms and ventilatory function in a middle-aged rural population. Eur J Respir Dis 1980; 61:33-45.
9. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow up of the Cracow study. Am Rev Respir Dis 1986; 134:1011-1019.
10. Heederik D, Kromhout H, Burema J, Biersteker K, Kromhout D. Occupational exposure and 25 years incidence rate of nonspecific lung disease - the Zutphen study. Int J Epidemiol 1990; 19:945-952.
11. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in Chronic Obstructive Lung Disease? Am J Respir Crit Care Med 2002; 166:329-332.
12. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson L-G, Lundbäck, B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005 May; 127(5):1544-1552.
13. Fletcher T, Peto R, Tinker C, et al. The Natural History of Chronic Bronchitis and Emphysema. Oxford, Oxford University Press, 1976.
14. Sherman CB, Xu X, Speizer FE, Ferris BG Jr., Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146:855-859.
15. 1: new insights into gender differences. Eur Respir J 1994 Jun; 7(6):1056-1061.
16. 1 decline and chronic obstructive pulmonary disease. Copenhagen City Heart Study. Am J Crit Care Med 1996 May;153(5):1530-1535.
17. Camilli A, Burrows B, Knudson R, Lyle SK, Lebowitz MD. Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987; 135:794-799.
18. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002 Sep 1; 166(5):675-679.
19. Rijcken B, Britton J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir Mon 1998 May; 7(3):s41-s73.
20. Lundbäck B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4(3):257-266.
21. Lundbäck B, Stjernberg N, Nyström L, Forsberg B, Lindström M, Lundbäck K, Jönsson E, Rosenhall L. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. Tuber Lung Dis 1994; 75(2):116-126.
22. Celli BR, MacNee W, and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
23. Medical Research Council's Committee on aetiology of chronic bronchitis - Standardized questionnaires on respiratory symptoms. Br Med J 1960; ii:1665.
24. Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland - a report from the FinEsS study. Chest 2001; 119:852-886.
25. Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit H-M, Larsson K, Laitinen LA. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med 2002; 96(10):759-769.
26. ATS statement. Snowbird workshop on standardization of spirometry. Am Respir Dis 1979; 119:831-838.
27. Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandqvist L, Söderholm B. Spirometric studies in normal subjects, Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173:185-192.
28. Statistics Sweden. The Socio-economic Classification of Occupations. Stockholm, Sweden, 1982.
29. Willemse BWM, Postma DS, Timens W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23:464-476.
30. Sherrill DL, Enright P, Cline M, Burrows B, Lebowitz MD. Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996; 109:1001-1005.
31. Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117(5 Suppl 2):339S-345S.
32. Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride NB. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55:789-794.
33. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10(4):822-827.
34. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21(6):1017-1023.
35. British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52 (Suppl 5):1S-28S.
36. 〈www.goldcopd.com〉
37. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20(5):1117-1122.
38. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22:268-273.
39. Lundbäck B, Stjernberg N, Nyström L, Lundbäck K, Lindström M, Rosenhall L. An interview study to estimate prevalence of asthma and chronic bronchitis. Eur J Epidemiol 1993 Mar; 9(2):123-133.